Parkinson's disease is marked clinically by motor dysfunction and pathologically by dopaminergic cell loss in the substantia nigra and iron accumulation in the substantia nigra. The driver underlying iron accumulation remains unknown and could be genetic or environmental. The HFE protein is critical for the regulation of cellular iron uptake. Mutations within this protein are associated with increased iron accumulation including in the brain. We have focused on the commonly occurring H63D variant of the HFE gene as a disease modifier in a number of neurodegenerative diseases. To investigate the role of H63D HFE genotype, we generated a mouse model in which the wildtype (WT) HFE gene is replaced by the H67D gene variant (mouse homolog of the human H63D gene variant). Using paraquat toxicity as the model for Parkinson's disease, we found that WT mice responded as expected with significantly greater motor function, loss of tyrosine hydroxylase staining and increase microglial staining in the substantia nigra, and an increase in R 2 relaxation rate within the substantia nigra of the paraquat-treated mice compared to their saline-treated counterparts. In contrast, the H67D mice showed a remarkable resistance to paraquat treatment; specifically differing from the WT mice with no changes in motor function or changes in R 2 relaxation rates following paraquat exposure. At baseline, there were differences between the H67D HFE mice and WT mice in gut microbiome profile and increased L-ferritin staining in the substantia nigra that could account for the resistance to paraquat. Of particular note, the H67D HFE mice regardless of whether or not they were treated with paraquat had significantly less tyrosine hydroxylase immunostaining than WT. Our results clearly demonstrate that the HFE genotype impacts the expression of tyrosine hydroxylase in the substantia nigra, the gut microbiome and the response to paraquat providing additional support that the HFE genotype is a disease modifier for Parkinson's disease. Moreover, the finding that the HFE mutant mice are resistant to paraquat may provide a model in which to study resistant mechanisms to neurotoxicants.
Iron plays a critical role in biological and physiological processes, including within the nervous system; in processes such as neurotransmission, neuronal metabolism, and myelination (Yu et al. 1986; Wigglesworth and Baum 1988) . Consequently, mismanagement of iron can result in significant effects on brain related diseases. Normally iron is enriched in the brain in areas such as the substantia nigra, globus pallidus, and red nucleus (Bilgic et al. 2012) . With age these regions can accumulate additional iron, and these elevated iron levels have been associated with Parkinson's Disease (Earle 1968; Dexter et al. 1987 Dexter et al. , 1989 Loeffler et al. 1995) . Parkinson's disease is a common neurodegenerative disease characterized by the loss of dopaminergic neurons located in the substantia nigra (SN) (Hirsch 1994) . Higher iron content in Parkinson's disease patients has been demonstrated by both postmortem and magnetic resonance imaging (MRI) studies (Dexter et al. 1987; Riederer et al. 1989; Gorell et al. 1995; Du et al. 2016; Wang et al. 2016) . The relationship between the pathogenic process of the disease and iron is not well understood. By the time of diagnosis, iron is elevated in the SN in Parkinson's disease (PD) patients. The over-riding question is whether iron increase in PD is a consequence or a driver of the disease. Free iron within the brain can induce reactive oxidative species promoting neuronal death and activation of microglia, which can contribute to the pathogenesis of Parkinson's Disease (Kruszewski 2003) . In PD, increased levels of brain iron can lead to elevated a-synuclein levels, which promote the formation of Lewy bodies (Spillantini et al. 1997) . Generation of Lewy bodies results in protein aggregates, a principal feature of Parkinson's disease (Forno 1969; Spillantini et al. 1997) .
One mechanism that could lead to iron dysregulation in the brain is genetic alterations. There has been increasing research on the iron management protein High Iron (HFE) which is thought to regulate cellular iron uptake by binding to transferrin receptor-1 (Lebr on et al. 1998; Bennett et al. 2000) . The two most well-studied HFE mutations are the C282Y and the H63D. The C282Y HFE gene variant is most commonly associated with hemochromatosis an iron overload disease which includes increased levels of iron within the brain (Nielsen et al. 1995; Berg et al. 2000) . The C282Y variant is much less prevalent than the H63D variant. The latter is found less frequently in hemochromatosis, but it is one of the most common gene variants in the Caucasian population (Feder et al. 1996; Burt et al. 1998; Marshall et al. 1999; Steinberg et al. 2001) . H63D HFE mutations have been reported as a disease modifier for neurodegenerative diseases such as Alzheimer's disease and amyotrophic lateral sclerosis (Nandar and Connor 2011) . The clinical association between HFE and PD remains unclear as there are conflicting results. Some studies have reported C282Y HFE variant has an increased frequency in PD, however, other studies do not find a connection between either the C282Y or H63D HFE mutations and PD (Borie et al. 2002; Buchanan et al. 2002; Dekker et al. 2003; Akbas et al. 2006; Guerreiro et al. 2006; Aamodt et al. 2007) . The lack of consistency in a relationship between HFE genotype and PD could be an example of gene-environment interaction. Iron must be obtained from the diet and the presence of HFE mutant proteins will increase the absorption relative to wild-type HFE (Ajioka et al. 2002) . Our lab has found the HFE genotype also alters the inflammatory response, possibly through impacting iron status or macrophage/microglia iron handling (Nixon et al. unpublished data) , which is considered part of the pathology of PD (Wang et al. 2008) . Using the mouse model we have developed that expresses the H67D HFE variant (the mouse homologue of the H63D variant), we hope to provide insight into the gene-environment relationship between paraquat sensitivity and HFE genotype.
Materials and methods
Animals C57BL/6J 9 129 mice (3-month old males) that contained either wild-type (WT) or knock-in of H67D alleles were used in this study (The Jackson Laboratory, Bar Harbor, ME, USA; RRID: IMSR_JAX:023025). The generation of the H67D mice was performed by inGenious Targeting Laboratory (Ronkonkoma, NY, USA) has been previously described (Tomatsu et al. 2003) . The H67D HFE mice were used as they are the mouse homolog of the H63D HFE human gene variant. The mice were individually housed in small standard mouse cages, within an in-house animal facility at The Pennsylvania State University College of Medicine. Mice had access to food and water ad libitum. The weight of the C57BL/ 6J 9 129 mice was not available. All procedures were approved by the Pennsylvania State University College of Medicine Institutional Animal Care and Use Committee (IACUC), protocol 46457. The study consisted of 24 animals, of which a subset of 20 animals were used for MRI and immunohistochemistry.
The study was not pre-registered.
Genotyping
To confirm the genotype of the mice, a portion of the tail was clipped and processed using DNeasy blood and tissue kit (Qiagen, Valencia, CA, USA). The extraction was amplified through PCR using following forward and reverse primers: (5 0 AGGACTCACTCTCTGGCAGCAGGAGGTAACCA3 0 ) and (5 0 TTTCTTTTACAAAGCTATATCCCCAGGGT3 0 ), with the following conditions; 4°C for 15 min, 94°C for 45 s, 58°C for 45 s, 39 cycles of 72°C for 90 s and 72°C for 10 min. Following PCR, the amplified DNA was digested for 2 h at 37°C using the restriction enzyme BspHI. The HFE genotype was confirmed by running the sample on a 1.5% TAE gel and imaged with GE Amersham Imager 600 (GE; Buckinghamshire, UK).
Paraquat and saline injections
The mice were arbitrarily divided into two groups which received either saline (control) or 10 mg/kg paraquat dichloride hydrate (Sigma Aldrich; St. Louis, MO, USA). The animals entered the study and were followed for 3 weeks to record body weight and food intake. Following the 3 week recording period, the animals were arbitrarily assigned to receive either paraquat or saline injections, which were given intraperitoneally once a week for 3 weeks (Fig. 1 ). Animals were only subjected to brief, minor discomfort and do not require anesthetics, per Penn State IACUC guidelines. Paraquat was chosen to mimic the dopaminergic cell loss in Parkinson's Disease (Brooks et al. 1999) .
Behavior
Motor performance was tested using a rotarod apparatus (Columbus Instruments, Columbus, OH, USA). On the second week of recording body weight and food intake, the mice were trained on the rotarod for 180 s at 15 rpm. Motor performance was tested twice; at week three, prior to paraquat or saline injections, and at week six, prior to the endpoint (Fig. 1) . The number of falls were recorded for each behavior test. To obtain a performance score, the number of falls from the second test were subtracted from the first.
Histology
At the endpoint of the experiment mice (N = 20 animals (5/g) from the MRI group) were transcardially perfused with Ringer's solution, following an intraperitoneal injection of ketamine/xylazine cocktail. Following, the brains were removed, hemisected, and preserved with 4% paraformaldehyde in 0.1 M phosphate-buffered saline (PBS). Following 24-h the paraformaldehyde was replaced with fresh paraformaldehyde for an additional 24 h. Lastly, paraformaldehyde was replaced with 70% ethanol until paraffin embedded.
Immunohistochemistry
Paraffin-embedded brain tissue was coronally sectioned into 5-lmthick slices. The sections were then deparaffinized and rehydrated through a series of xylene, ethanol, and finally deionized water. Rehydration was followed by antigen retrieval using sodium citrate (pH 6.0) and then hydrogen peroxide to block endogenous peroxidases (20 min at 21°C). The sections were then blocked in 2% milk in 19 phosphate-buffered saline (PBS) for an hour at 21°C, followed by overnight incubation with 1 : 1000 tyrosine hydroxylase (Pel-Freez Biologicals; Rogers, AK, USA; RRID: AB_2313713), 1 : 1000 L-ferritin (Abcam; Cambridge, MA, USA; RRID:AB_1523609), 1 : 1000 IBA-1 (Wako; Richmond, VA, USA; RRID:AB_2665520), or 1 : 1000 GFAP (Dako, Carpinteria, CA, USA; RRID:AB_10013482). The sections were washed and then incubated with 1 : 200 biotinylated anti-host secondary antibody (Vector Laboratories; Burlingame, CA, USA) for 1-h at 21°C. Immunoreactivity was detected using the avidin biotin complex and 3,3 0 -diaminobenzidine (DAB) (Vector Laboratories;
RRID:AB_2336382, AB_2336793, and AB_2336798). The sections were imaged using the whole-slide scanner, Aperio AT, and quantitatively analyzed using ImageJ software (NIH; Bethesda, MD, USA) images. DAB-induced staining intensity was quantified within a constant region of interest surrounding the substantia nigra across all samples. Signal above a constant threshold was used to calculate the area positive for DAB within the region of interest (i.e. area fraction). During immunohistochemistry and analysis, investigators were blinded to treatment groups and genotype. Following completion of analysis, the investigators were un-blinded to complete statistical assessment.
Iron staining
A modified Perls' stain was used to assess iron within tissue sections (Sands et al. 2016) . Five-lm paraffin-embedded sections were deparaffinized and rehydrated using SafeClear Xylene Substitute (2 9 3 min; Thermo Fisher Scientific, Waltham, MA). Slides were then air-dried for approximately 30 min. To stain for iron, slides were incubated with 1% potassium ferrocyanide trihydrate, 5% poly (vinylpyrrolidinone) (PVP), and 0.05 N HCl solution for 60 min at 21°C. Slides were quickly rinsed twice in water, and then blocked using methanol containing 0.3% hydrogen peroxide for 75 min. Next, the slides were washed twice in 19 phosphate-buffered saline (PBS) for 5 min. The slides were then placed into SafeClear Xylene Substitute prior to cover slipping with Cytoseal-60 mounting media (Thermo Fisher Scientific). The sections were imaged using an Aperio AT whole-slide scanner, and quantitatively analyzed using ImageJ software as stated in the immunohistochemistry subsection.
Magnetic resonance imaging
Image acquisition A subset of 20 animals (N = 5/group) were anesthetized with 1.5% isoflurane, placed within a 35 mm birdcage volume coil using a Fig. 1 Schematic Timeline of the Study Design. The food and body weight of the mice were taken each week throughout the 7-week period. Behavioral training began at week two and then performance on the behavioral tests was scored at weeks three and six. Following the first behavior test, the mice were arbitrarily divided into groups and given paraquat or saline injections once a week for 3 weeks. Following the last behavior test, the animals were sacrificed and tissue was harvested. A subset of the animals (5/group) were arbitrarily selected for magnetic resonance imaging (MRI) analysis after the last behavioral test.
standardized animal bed, and imaged with a 7.0 T Bruker BioSpec 70/20 MRI system (Bruker BioSpin, Ettlingen, Germany). Animals were imaged with the same protocol at baseline prior to paraquat exposure and 3-weeks later following paraquat treatment ( Fig. 1) . A multi-echo three-dimensional RARE spin-echo T2-weighted protocol was utilized with the following parameters: averages = 2, relaxation time = 2000 ms, rare-factor = 8, four echoes with effective echo time = 30-120 ms with an echo spacing of 30 ms, field of view = 25 9 25 9 15 mm, and acquisition matrix = 256 9 256 9 32, for a final voxel resolution of 97 9 97 9 468 lm.
MRI parametric analysis
Transverse relaxation rate (R 2 ) maps were generated using a nonlinear least squares curve fitting model on a pixel-by-pixel basis (Dardzinski et al. 1997; Koff et al. 2008 ) with qMRI software running in IDL 8.1. The first echo from each dataset was then skullstripped with in-house software in SPM8 (Wellcome Trust Centre for Neuroimaging, UK) and applied to all remaining echoes before spatial processing. The skull-stripped first echo was then used as an anatomical image to spatially realign and co-register the parametric maps to a template mouse brain (Ma et al. 2008) . Anatomical images and parameter maps were then normalized and resliced to the Magnetic Resonance Microimaging Neurological Atlas (MRM NeAt) template mouse brain (Ma et al. 2005 (Ma et al. , 2008 ) with a voxel size of 100 9 100 9 100 lm using SPM8 and the SPMmouse v1.1b toolkit (Sawiak et al. 2009 ), followed by smoothing with a 400 lm isotropic Gaussian smoothing kernel.
Gut microbiome
Wetlab analysis Samples (n = 12) were collected and shipped to Wright Labs, LLC. Nucleic acid extractions were performed on approximately 0.25 g of each sample using a MoBio Powersoil DNA Isolation kit following the manufacturer's instructions (MoBio, Carlsbad, CA, USA). The vortexing step was performed using the Disruptor Genie cell disruptor (Scientific Industries, Bohemia, NY, USA). The resulting genomic DNA was eluted in 50 lL of 10 mM Tris. The Qubit 2.0 (Invitrogen, Carlsbad, CA, USA) Fluorometer according to the protocol of the dsDNA high sensitivity option was then utilized to quantify total DNA. Illumina iTag Polymerase Chain Reactions (PCR) were performed at a total volume of 25 lL for each sample and contained final concentrations of 19 PCR buffer, 0.8 mM dNTP's, 0.625 U Taq, 0.2 lM 515F forward barcoded primer, 0.2 lM Illumina reverse 806R primer and~10 ng of template DNA per reaction. PCR was carried out on a MJ Research PTC-200 thermocycler (BioRad, Hercules, CA, USA) using the following cycling conditions: 98°C for 3 min; 35 cycles of 98°C for 1 min, 55°C for 40 s, and 72°C for 1 min; 72°C for 10 min; and kept at 4°C. PCR products were visualized on a 1% CYBRsafe E-gel (Caporaso 2010) A.
Pooled PCR products were gel purified using the Qiagen Gel Purification Kit (Qiagen, Frederick, MD, USA). Clean PCR products were quantified using the Qubit 2.0 Fluorometer (Life Technologies, Carlsbad, CA, USA), and samples were combined in equimolar amounts. Prior to submission for sequencing, libraries were quality checked using the 2100 Bioanalyzer DNA 1000 chip (Agilent Technologies, Santa Clara, CA, USA). Pooled libraries were stored at À20°C until they were shipped on dry ice to Laragen (Culver City, CA, USA) for sequencing.
Library pools were size verified using the Fragment Analyzer CE (Advanced Analytical Technologies Inc., Ames, IA, USA) and quantified using the Qubit High Sensitivity dsDNA kit (Life Technologies). After dilution to a final concentration of 1 nM and a 10% spike of PhiX V3 library (Illumina, San Diego, CA, USA), pools were denatured for 5 min in an equal volume of 0.1 N NaOH then further diluted to 12 pM in Illumina's HT1 buffer. The denatured and PhiX-spiked 12 pM pool was loaded on an Illumina MiSeq V2 500 cycle kit cassette with 16S rRNA library sequencing primers and set for 250 base, paired-end reads.
Bioinformatics analysis
Paired-end sequences were filtered at an expected error of less than .5% using USEARCH v7 (Edgar 2013 ). After quality filtering, reads were analyzed using the QIIME 1.9.0 software package (Caporaso et al. 2010 (Caporaso et al. , 2011 . Chimeric sequences were identified using USEARCH61 (Edgar 2010) . A total of 720 807 sequences were obtained after quality filtering and chimera checking. Open reference operational taxonomic units (OTUs) were picked using the USEARCH61 algorithm (Edgar 2010) , and taxonomy assignment was performed using the Greengenes 16S rRNA gene database (13-5 release, 97%) (DeSantis et al. 2006) . Assigned taxonomy were organized into a BIOM formatted OTU table, which was summarized within QIIME 1.9.0. (Note: an OTU table contains each collected sample and the abundance of each unique bacterial taxon identified within its respective sample).
Alpha diversity plots were generated within the QIIME 1.9.0 sequence analysis package using an unrarified OTU table. Rarefaction was conducted on sequences across all samples to a maximum depth of 43 000 sequences with a step size of 4300 sequences per sample, for 20 iterations. Alpha diversities were then collated, plotted and compared considering observed species richness metrics. Alpha diversity was compared between experimental cohorts using a two-sample t-test and non-parametric Monte Carlo permutations (n = 999).
Relative abundances of taxa were multiplied by 1 million and formatted as described in (Segata et al. 2011) . Comparisons were made with 'Cohort' as the main categorical variable ('Class'). Alpha levels of 0.05 were used for both the Kruskal-Wallis and pairwise Wilcoxon tests. Linear discriminant analysis scores greater than 2.0 are plotted on each respective pairwise cladogram.
Statistical analysis
Statistical analyses for behavior data and histologically sections were analyzed using Graphpad Prism (La Jolla, CA, USA), in which the results were presented as mean AE SD. Statistical comparisons were completed by either a ungrouped t-test or a two-way ANOVA, with Tukey's multiple comparison test. A p < 0.05 was considered statistically significant. Outliers were excluded if they were statistically different from the other values.
MRI statistical analyses consisted of group based statistical parametric two-sample t-tests between the WT, H67D, paraquat, and saline-treated groups at baseline and 3-week time points using SPMmouse. Group-based interaction effects between H67D and WT genetics over time were performed on the normalized R 2 parametric maps using a modified SPM contrast matrix with an absolute threshold for voxel cluster ≥ 50 in size with p ≤ 0.005.
No information on replication is included as the study was only performed once.
Results
The amount of food consumed and body weight was measured every week over the course of the 7-week experiment. There were no significant differences between genotype and treatment groups (Fig. 2a and b) .
Effect of paraquat on motor function
Following 3 weeks of paraquat or saline injections, wildtype mice receiving paraquat injections had a greater number of falls (p < 0.05) compared to the wild-type saline-injected mice (Fig. 3 ). There were no significant differences in the number of falls between H67D HFE mice receiving paraquat or saline injections (Fig. 3) . MRI analysis revealed a unilateral longitudinal increase in R 2 relaxation rate for the paraquat-injected wild-type mice compared to the wild-type saline-injected mice, specifically within the regions of the substantia nigra (Fig. 4-top) . In contrast, there were no significant changes in R 2 relaxation rate between H67D HFE paraquat and saline-injected mice (Fig. 4-bottom) .
Tyrosine hydroxylase immunostaining
The effect of paraquat treatment on tyrosine hydroxylase (TH) immunostaining within the substantia nigra pars compacta revealed a 58% loss of TH positive staining in the pars compacta of the wild-type paraquat-injected mice compared to the wild-type saline-injected mice ( Fig. 5b and  d ; p < 0.05). The H67D mice have 71.5% less TH staining than wild-type mice ( Fig. 5a and c; p < 0.01 and p < 0.05), but there is no significant difference in TH staining between H67D paraquat and saline-injected groups.
L-ferritin levels within the substantia nigra Next, we evaluated differences in the long-term iron storage protein, L-ferritin. The cells that stained positive for Lferritin resembled microglia and oligodendrocytes, regardless of genotype or treatment (Fig. 6a) . In the pars compacta, quantitative analysis revealed that H67D saline-injected mice have approximately twice the amount of L-ferritin immunostaining compared to H67D paraquat-injected mice ( Fig. 6b ; p < 0.05). In addition, the amount of L-ferritin staining in the H67D saline-injected mice was significantly greater than Fig. 2 Mean Food Intake and Change in Body Weight. To ensure treatment or genotype did not impact food intake (a) or body weight (b), mean food intake and change in body weight was measured. Food was weighed out at the beginning and end of each week to determine food intake. At the same time points each mouse was weighed and change in body weight was assessed. There were no significant differences in mean food intake or change in body weight across treatment/genotype groups. Data represent the mean AE SD and are compared to all treatment groups for statistical significance using two-way ANOVA. (N = 5 or 6/group).
Fig. 3 Behavior Analysis of Motor Function between Genotype and
Treatment Groups. Motor performance was assessed using a rotarod, in which the number of falls from the two behavior tests were subtracted from each other. An increase in the number of falls indicates a decrease in motor performance and increase in disease progression. The wild-type paraquat-injected mice had an increase in number of falls compared to their saline controls. There was no significant difference in the number of falls between the H67D treatment groups. Data represent the mean AE SD and are compared to all treatment groups for statistical significance using two-way ANOVA. *p < 0.05; N = 5 or 6/group. wild-type-injected saline and paraquat mice ( Fig. 6b ; p < 0.01). Paraquat injections had no effect on L-ferritin staining in the wild-type mice. L-ferritin levels within the pars reticulata were similar to pars compacta, in which H67D saline-injected mice had significantly greater L-ferritin levels compared to wild-type paraquat mice. In addition, H67D paraquat-injected mice had increased L-ferritin levels compared to wild-type paraquat mice ( Fig. 6c ; p < 0.05).
Microglia and astrocyte changes within substantia nigra
To interrogate the role of gliosis in these models, we examined markers of astrocytes and microglia. In wild-type mice with paraquat injections there was a 3-fold increase in microgliosis within the pars compacta of the substantia nigra compared to the saline-injected wild-type mice, however, the difference was not statistically significant (Fig. 7e) . In contrast, there was statistically significant microgliosis within the pars reticulata of the wild-type paraquat-injected mice, in which there was four times the amount of microglia present compared to the wild-type saline mice. The wild-type paraquat-injected mice had about four times the amount of microglia compared to the H67D HFE paraquat-injected mice also within the pars reticulata ( Fig. 7f ; p < 0.01). Despite the increase in microgliosis, there was no astrogliosis observed within the wild-type paraquat-injected mice in either the pars compacta or pars reticulata ( Fig. 8e and f) . There was no significant astrogliosis present in the H67D HFE mice within both regions of the substantia nigra (Fig. 8f) .
Iron accumulation within the substantia nigra Substantia nigra sections were stained with a modified Perls' stain. At the cellular level, all the iron stained cells appeared There is significantly less TH expression within the substantia nigra of the H67D HFE saline (a, e) and H67D HFE paraquat-treated (c, e) mice compared to wild-type saline-treated (b, e) mice. Wild-type paraquat-injected mice (d, e) have a significant decrease of tyrosine hydroxylase expression within the substantia nigra compared to wild-type saline mice (b). Scale bar is equal to 300 lm. Data represent the mean AE SD and are compared to all treatment groups for statistical significance using two-way ANOVA.
*p < 0.05, **p < 0.01, ***p < 0.001; N = 5/group. to be oligodendrocytes (Fig. 9a ). There were no significant differences in iron accumulation within the pars reticulata of the substantia nigra. In addition, there were no significant differences between genotype or treatment groups (Fig. 9b) .
Gut microbiome
Alpha diversity analysis revealed a rich bacterial community composition within each respective experimental cohort, as average species richness yielded more than 300 observed There were no differences in microglial expression within the substantia nigra pars compacta (e). However, there is significantly more microglia present within the substantia nigra pars reticulata of wild-type paraquatinjected mice compared to wild-type saline mice and H67D HFE paraquat mice (f). Scale bar is equal to 300 lm. Data represent the mean AE SD and are compared to all treatment groups for statistical significance using two-way ANOVA. **p < 0.01; N = 5/group. species per cohort (Fig. 10) . Elevated species richness (observed species 386.06 AE 6.43) was observed within the H67D HFE cohort in comparison to the WT cohort (observed species 315.77 AE 15.30). Differences in species richness between cohorts were not found to be significantly differential (two-sample t-test with Monte Carlo permutations p > 0.05).
Taxa enrichment cladograms (Fig. 11 ) revealed significantly (Kruskal-Wallis p < 0.05, linear discriminant analysis score > 2.0) enriched bacterial taxa within WT male and H67D male cohorts. In total, over 35 lineages of bacterial taxa were found to be significantly differential between the two experimental cohorts. Within the H67D male samples, an enrichment of taxa within the Acidobacteria, Firmicutes, Deltaproteobacteria, and Tenericutes were observed. These taxa were conversely considered significantly depleted within WT male samples. Bacterial taxa within Bacteroidetes, Actinobacteria, Verrucomicrobia, Betaproteobacteria, Alphaproteobacteria, and Erysipelotrichi were significantly enriched within WT samples. The data suggest a distinct There were no differences in astroglial expression within the substantia nigra pars compacta (e) and pars reticulata (f), between any treatment or genotype groups. Scale bar is equal to 300 lm. Data represent the mean AE SD and are compared to all treatment groups for statistical significance using two-way ANOVA. (N = 5/group). Fig. 9 Iron (Perls' Stain) Expression in the Substantia Nigra. A representative image from a coronal section stained with the Perls' reaction for iron shows iron positive oligodendrocytes. (a) There were no significant differences in extent of iron staining within the substantia nigra pars compacta and pars reticulata, between any treatment or genotype groups. Scale bar is equal to 100 lm. Data represent the mean AE SD and are compared to all treatment groups for statistical significance using two-way ANOVA. (N = 5/group). change in microbial community composition between experimental cohorts.
Discussion
In this study, we demonstrate that wild-type mice injected with paraquat develop motor impairment, changes in MRI that reflect alterations in regional cellularity, loss of TH immunostaining, and increased microgliosis. However, paraquat did not induce neurological changes within the H67D model, indicating the H67D HFE gene variant establishes a resistant milieu against paraquat. The H67D HFE mice had a significantly higher level of L-ferritin within the pars compacta than the WT mice, that could be part of the protective milieu in the SN, in which the elevated ferritin would sequester iron and prevent cellular damage. The ferritin levels decreased in the mutant mice after the paraquat injections, but the beginning higher level may have been sufficient to offer protection. The elevated levels of ferritin are consistent with an MRI study which demonstrated an increase in relaxation rate within the male H63D carrier brain (Bartzokis et al. 2010) . In which elevated ferritin could be protective is consistent with Kaur et al. (2003) who found over-expression of H-ferritin in TH neurons limited loss of these cells. Our study suggests that a natural, genetic driven increase in L-ferritin may also have a protective effect.
One of the pathological hallmarks of Parkinson's disease is the progressive degeneration of dopaminergic neurons within the pars compacta region of the substantia nigra, resulting in the loss of motor function and the progression of the disease (Hirsch 1994) . Tyrosine hydroxylase is an enzyme that contributes to the formation of dopamine within neurons in the substantia nigra and is used as a surrogate marker for the dopaminergic neurons (Daubner et al. 2011) . The loss of tyrosine hydroxylase expression within the wild-type mice injected with paraquat corresponds with the decreased motor function, and is consistent with the loss of TH positive neurons and loss of motor control in PD patients (Gelb et al. 1999) . The etiology of neurotoxicity induced by paraquat is not well understood, but thought to be the result of oxidative stress (McCarthy et al. 2004) . In this study, associated with the loss of TH immunostaining in the wild-type mice, was an increase in microglia. Purisai et al. (2007) demonstrated paraquat induced activation of microglia of NADPH-oxidase was the key event leading to paraquat induced dopaminergic neuron loss. However, minocycline, an anti-inflammatory drug that can also chelate iron (Chen-Roetling et al. 2009 ), protected against paraquat oxidative stress and loss of TH+ neurons (Purisai et al. 2007) . We have previously shown that minocycline will decrease the expression of monocyte chemoattractant protein-1 (Mitchell et al. 2009 ) in cells expressing the mutant HFE protein but not in WT HFE cells. Monocyte chemoattractant protein-1 is secreted to stimulate the recruitment of macrophages and microglia during inflammation. The higher expression of L-ferritin in the microglia of the mutant mice before paraquat could have limited the inflammatory response by sequestering iron, and the signals from the activated microglia could be less proinflammatory with the HFE H67D mutation (Nixon et al. unpublished data) . Astrocytes are also engaged in the inflammatory response in the brain (Claycomb et al. 2013) , but there was not a significant difference in astrocyte expression profiles between the wild-type paraquat and saline-injected groups. Because the paraquat injection paradigm that we used is an acute model, the lack of significant increase in astrocytes may suggest these cells are more involved in a chronic disease process.
MRI analysis was performed twice, once at baseline and a second time following 3-week paraquat exposure prior to sacrifice. The increase in MRI R 2 rate in wild-type mice injected with paraquat are consistent with a regional change in cellular content (Kamman et al. 1984; Ranade 1988; Koenig et al. 1990; Kucharczyk et al. 1994; Abdolmohammadi et al. 2016) , consistent with the loss of dopaminergic neurons and/or an increase in microglia proliferation within the outlined region. It is interesting to note that the MRI differences were unilateral and located in the left side of the brain. This finding is very intriguing because the onset of PD motor symptoms is typically asymmetric (Riederer and Sian-H€ ulsmann 2012) and more often present on the right side of the body (Uitti et al. 2005) . Moreover, we recently demonstrated that farmers exposed to pesticide have more left than Fig. 10 Alpha diversity within the gut microbiome. Alpha diversity analyses were generated to compare species richness between male wild-type (WT) and H67D HFE mice. Here, we can observe elevated species richness within the H67D HFE group. Differences were not found to be statistically significant likely because of low sample size (N = 3) within each group. right side MRI changes in the basal ganglia (Lewis et al. 2017) .
A recent topic of interest in the field of Parkinson's disease is the interplay between the gut microbiome and disease. Because the presence of H67D HFE appears to confer resistance to paraquat, we performed a small exploratory study to compare the gut microbiota of H67D HFE to wildtype mice. The data demonstrated enriched taxa in male H67D HFE microbiome as compared to wild-type. Further examination of the relationships between bacterial communities and abundance provided even more provocative results, with significant differences in 45 taxa. Six of the identified taxa recapitulated recently published data demonstrating a shift in the microbial community in Parkinson's disease patients consistent with our observed resistance to paraquat in the H67D HFE mice. Bacteria from the buytrateproducing Firmicutes phyla overall are increased in H67D HFE, with the Lachnospiraceae family and Blautia genus specifically identified as taxa of enrichment, is consistent with data in the human population where neurologically normal controls have increased levels of these bacteria as compared to Parkinson's disease patients (Keshavarzian et al. 2015; Hill-Burns et al. 2017) . Likewise, microbes from the Bacteroidetes phyla are decreased in H67D HFE mice, predominantly the Akkermansia genus in the Verrucomicrobiaceae family while they are elevated in Parkinson's patients (Keshavarzian et al. 2015; Hill-Burns et al. 2017) . Collectively, the data suggest that inherent differences in the microbiome in H67D HFE mice are worthy of future study in the context of Parkinson's disease models.
Whereas the wild-type mice injected with paraquat depicted histological and behavioral changes consistent with previous reports, there were significant differences between WT and H67D mice in the response to paraquat. Fig. 11 Comparison of microbiota taxa between wild-type (WT) versus H67D HFE male mice. Cladogram plots display phylogenetic relationships of significantly (p < .05, linear discriminant analysis > 2.0) enriched taxonomy within respective cohorts of interest. Here, we observe significantly differential taxa between WT and mutant male mice. A high number (over 45) differentiating taxa can be observed, indicating a strong shift in microbial community composition between WT and H67D mice.
The H67D HFE mice had significantly less TH staining at the beginning of the study than the wild-type mice. There was no significant change in TH staining in the H67D HFE mice receiving paraquat injections suggesting that the remaining cells had developed a resistance or were protected by surrounding glial cells. Our laboratory has previously shown the H67D HFE mice have increased levels of NrF2 (Nandar et al. 2013) . Increased transcription of NrF2 in response to paraquat is protective from damage induced by paraquat, such as endoplasmic reticulum (ER) stress and mitochondrial dysfunction (Chen et al. 2012; Izumi et al. 2015) . Somewhat paradoxically, an activator of ER stress, XBP-1, results in protective effects against dopaminergic neuronal death in mice injected with 1-methyl-4-phenylpyridinium. In a cell model, SH-SY5Y cells carrying the H63D HFE gene variant have increased levels of spliced XBP-1 protein which would also be consistent with resistance to paraquat in the H67D HFE mice. We cannot at this time discern if the baseline decrease in TH staining in the HFE H67D mice is a failure to develop normally or from neurodegeneration that occurred as the substantia nigra began to accumulate iron with age. Our data suggest that the initial decrease in TH expression could result from a flaw in development, because there were no differences found in the longitudinal MRI analysis that are indicative of ongoing inflammation, nor was there evidence of gliosis. Moreover, there is not an increase in iron uptake in the brain during development in the mice expressing the H67D HFE variant compared to WT; even though iron accumulation is greater over time (Duck et al. 2017) . Thus, there appears to be an adaptive period to the presence of the HFE mutation in the brain which may stabilize the cellular milieu and offer resistance to stress. The H67D HFE mice injected with saline did have on average a higher number of falls than the wild-type saline-injected mice, however, the difference was not statistically significant. Nonetheless, the observation would suggest some degree of underlying motor impairment in the mutant mice associated with the significant loss of TH. The data, however, do suggest, as also observed in PD, that significant neuronal loss must occur prior to clinical presentation of the disease (Marsden 1990 ). The limited motor impairment in the HFE mice further suggests that the lack of TH expression in this model is a developmental variant to which the animal has adapted. In either event, the data indicate that the HFE H67D mice could be an interesting model for development and vulnerability of the TH positive neurons.
In summary, we examined the effect of the H67D HFE gene variant on neurodegeneration in a paraquat mouse model. We conclude the H67D genotype establishes a milieu that limits gliosis and loss of TH neuronal staining induced by paraquat. This effect may be mediated by the increased expression of L-ferritin, and increased anti-oxidant indices. The H67D HFE mouse provides a model in which to study paraquat resistance. Furthermore, these results continue to support the concept that this gene variant is a disease modifier that must be considered in this era of personalized medicine.
